A Kinetic Model for Blood Biomarker Levels After Mild Traumatic Brain Injury

Area of Science:

• Neuroscience
• Biomarker Research
• Kinetic Modeling

Background:

• Mild traumatic brain injury (TBI), or concussion, presents diagnostic and prognostic challenges, particularly in athletes.
• Accurate assessment of concussion severity and recovery is difficult, impacting return-to-play decisions.
• Blood biomarkers show potential for TBI diagnosis and prognosis, but their dynamic changes over time require further investigation.

Purpose of the Study:

• To develop and validate a one-compartment kinetic model for tracking blood biomarker levels after mild TBI.
• To assess the feasibility of modeling the kinetic behavior of specific biomarkers including S100B, UCH-L1, NF-L, GFAP, and tau.
• To explore the potential diagnostic implications of modeling biomarker trajectories.

Main Methods:

• Proposed a one-compartment kinetic model adapted from pharmacokinetic principles for oral drug absorption.
• Approximated model parameters using data from previously published studies.
• Conducted uncertainty and sensitivity analyses due to approximate parameter estimates.
• Applied the developed model to an existing dataset of UCH-L1, GFAP, tau, and NF-L biomarker levels post-concussion.

Main Results:

• Demonstrated the feasibility of using a one-compartment kinetic model to describe blood biomarker levels following mild TBI.
• The model successfully applied to a dataset, illustrating the dynamic changes in key biomarkers.
• Initial parameter estimates provided insights into biomarker kinetic behavior.

Conclusions:

• A one-compartment kinetic model is a feasible approach for understanding blood biomarker dynamics after mild TBI.
• Further research is needed to refine model parameters for improved accuracy.
• This modeling approach holds potential for enhancing the diagnostic utility of blood biomarkers in mild TBI cases.